Oxytocin — Discount Pricing

Other medications in Women's Health

• Progesterone Vaginal
• Relugolix
• Terbutaline
• Betamethasone Prenatal
• Carboprost
• Clomiphene Citrate
• Danazol
• Desogestrel-Ethinyl Estradiol

What Oxytocin is approved for (FDA label)

IMPORTANT NOTICE: Oxytocin Injection, USP (synthetic) is indicated for the medical rather than the elective induction of labor. Available data and information are inadequate to define the benefits to risks considerations in the use of the drug product for elective induction. Elective induction of labor is defined as the initiation of labor for convenience in an individual with a term pregnancy who is free of medical indications. Antepartum Oxytocin injection (synthetic) is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable, in order to achieve early vaginal delivery for fetal or maternal reasons.

Source: Read the full FDA label on DailyMed. Label effective date: September 1, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Oxytocin (FDA label)

To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. The following adverse reactions have been reported in the mother: Anaphylactic reaction Postpartum hemorrhage Cardiac arrhythmia Fatal afibrinogenemia Nausea Vomiting Premature ventricular contractions Pelvic hematoma Excessive dosage or hypersensitivity to the drug may result in uterine hypertonicity, spasm, tetanic contraction or rupture of the uterus. The possibility of increased blood loss and afibrinogenemia should be kept in mind when administering the drug. Severe water intoxication with convulsions and coma has occurred, and is associated with a slow oxytocin infusion over a 24-hour period. Maternal death due to oxytocin-induced water intoxication has been reported.

Source: FDA prescribing information (DailyMed). Set ID: b6f20a2c-3609-4b09-b8f7-8d8eaeb5c242. SPL document ID: 5a6d19ba-e226-8433-e063-6394a90a1028. Label effective date: September 1, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Oxytocin (FDA label)

Oxytocin injection (synthetic) is contraindicated in any of the following conditions: Significant cephalopelvic disproportion; Unfavorable fetal positions or presentations which are undeliverable without conversion prior to delivery, i.e., transverse lies; In obstetrical emergencies where the benefit-to-risk ratio for either the fetus or the mother favors surgical intervention; In cases of fetal distress where delivery is not imminent; Prolonged use in uterine inertia or severe toxemia; Hypertonic uterine patterns; Patients with hypersensitivity to the drug; Induction or augmentation of labor in those cases where vaginal delivery is contraindicated, such as cord presentation or prolapse, total placenta previa, and vasa previa.

Source: FDA prescribing information (DailyMed). Set ID: b6f20a2c-3609-4b09-b8f7-8d8eaeb5c242. SPL document ID: 5a6d19ba-e226-8433-e063-6394a90a1028. Label effective date: September 1, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.